HTBT
Hefei · Founded 2007
About HTBT
HTBT is an enterprise dedicated to the introduction and research and development of diabetes series products and technologies, the construction of industrial clusters of protein oral drug delivery platforms, and the provision of full-course management services for diabetic patients. With flagship goods such oral insulin capsules, recombinant human insulin, insulin analogs, and GLP-1, HTBT aims to establish itself as a credible and reliable biopharmaceutical company and a global biopharmaceutical product R&D and production base (GLP-1 receptor agonists).
Company Facts
- Founded: 2007
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $33.4M
- Funding stage: Late Stage Venture
- Last round: Series E (Dec 2016)
- Website: htbt.com.cn
- Phone: 86-551-63849080
Industries & Categories
Biopharma, Biotechnology, Information Technology, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/htbt-74536 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.